Trial · NCT01752400

Results by group12

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 12 of 12

Outcome	Group	Category	Value	Spread	Units
Objective Response Rate	AUY922		0		Participants
Progression-free Survival	AUY922		1.43	95% Confidence Interval 1.3 to 2.8	Months
Disease Control Rate	AUY922	CR	0		Participants
Disease Control Rate	AUY922	PR	3		Participants
Disease Control Rate	AUY922	SD	3		Participants
Number of Participants Who Develop Adverse Events on AUY922	AUY922		6		Participants
Number of Participants With Concurrent KRAS Mutations	AUY922	KRAS Mutation	0		Participants
Number of Participants With Concurrent KRAS Mutations	AUY922	Negative for KRAS Mutation	2		Participants
Number of Participants With Concurrent KRAS Mutations	AUY922	Unknown Mutation Status	4		Participants
ALK Mutation Status	AUY922	ALK Mutation	1		Participants
ALK Mutation Status	AUY922	No ALK Mutation	0		Participants
Median Overall Survival	AUY922		26.87	95% Confidence Interval 9.03 to 26.87	Months

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01752400/results